novo nordisk glp-1 receptor agonist agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal glp-1_analogs [TUSOM | Pharmwiki]

These findings collectively support the anti-apoptotic actions of GLP-1RAs as part of their effects on endothelial dysfunction

10.1158/0008-5472.CAN-07-6161 Cancer Res

Tette FM, Kwofie SK, Wilson MD

Other experimental work shows that different IGF-1 isoforms may produce different muscle responses, which supports the idea that splice-variant context matters [11]

Record lot information within research tracking systems and follow institutional contamination control procedures

Encounter Data and Audits: CMS has been shifting toward using encounter data (detailed records of services provided) to calibrate payments, instead of solely insurer-reported summaries